APP and neuroblastoma: CRAM-1 blocks proteasomal degradation of ubiquitinated proteins and thus promotes aggregation (Ayyadevara et al. 2015) and SERF2 promotes aggregation of Aβ in human neuroblastoma cells overexpressing APP (amyloid precursor protein) (Balasubramaniam et al. 2018).